URL details: orf-blog.com/2020/01/19/bracing-for-a-hematology-faceoff-cars-vs-bispecifics/#comments
URL title:
Bracing for a hematology faceoff: CARs vs. bispecifics | Open Reading Frame
URL description:
After a challenging period, bispecific antibodies (bsAbs) are making a comeback in hematology as they become a prominent drug class and a major threat to CARs. Historically, excitement around bsAbs peaked in 2012 following the Amgen (AMGN)/Micromet acquisition but gradually faded due to disappointing results for Amgen’s Blincyto and other bsAbs. Blincyto (a CD19xCD3 T…
URL last crawled:
2022-06-29
URL speed:
1.010 MB/s,
downloaded in 0.100 seconds
We found no external links pointing to this url.